WY
14
-5
VRTX
61
-2
AIG
33
-3
HPE
34
-2
RL
46
-4
ZBH
80
-4
COF
23
-5
MCD
65
-2
ACN
33
-5
BBY
41
-3
NOV
49
-3
HSIC
53
8
IR
55
-2
HAL
55
-3
O
26
-11
TRV
49
-4
AAP
20
-3
MSI
61
-3
FMC
65
-5
HRB
52
-3
WY
14
-5
VRTX
61
-2
AIG
33
-3
HPE
34
-2
RL
46
-4
ZBH
80
-4
COF
23
-5
MCD
65
-2
ACN
33
-5
BBY
41
-3
NOV
49
-3
HSIC
53
8
IR
55
-2
HAL
55
-3
O
26
-11
TRV
49
-4
AAP
20
-3
MSI
61
-3
FMC
65
-5
HRB
52
-3
Financhill
Back

Gilead Sciences 10K Form

Buy
60

GILD
Gilead Sciences

Last Price:
78.80
Seasonality Move:
2.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-02-25 10K GILD/Gilead Sciences Annual
2020-11-04 10Q GILD/Gilead Sciences Quarterly
2020-08-06 10Q GILD/Gilead Sciences Quarterly
2020-05-06 10Q GILD/Gilead Sciences Quarterly
2020-02-25 10K GILD/Gilead Sciences Annual
2019-11-05 10Q GILD/Gilead Sciences Quarterly

Receive GILD News And Ratings

See the #1 stock for the next 7 days that we like better than GILD

GILD Financial Statistics

Sales & Book Value

Annual Sales: $27.28B
Cash Flow: $2.39B
Price / Cash Flow: 11.76
Annual Sales: $17.03
Price / Book: 4.57

Profitability

EPS (TTM): 3.65000
Net Income (TTM): $4.59B
Gross Margin: $21.62B
Return on Equity: 22.17%
Return on Assets: 7.18%

Gilead Sciences Earnings Forecast

Key Gilead Sciences Financial Ratios

  • The Gross Profit Margin over the past 32 years for GILD is 79.26%.
  • The Selling, General & Administrative Expenses for GILD have been equal to 20.79% of Gross Profit Margin.
  • The Research & Development expenses have been 18.24% of Revenue.
  • The Interest Expense is 20.36% of Operating Income.
  • The Net Earning history of GILD is 16.83% of Total Revenues.
  • Per Share Earnings over the last 32 years have been positive in 18 years.

Gilead Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Drug Manufacturers - General
Sector: Healthcare
Current Symbol: GILD
CUSIP: 375558
Website: gilead.com

Debt

Debt-to-Equity Ratio: 1.19
Current Ratio: 1.29
Quick Ratio: 0.99

Price-to-Earnings

Trailing P/E Ratio: 21.36
Forward P/E Ratio: 10.72

GILD Technical Analysis vs Fundamental Analysis

Buy
60
Gilead Sciences (GILD) is a Buy

Is Gilead Sciences a Buy or a Sell?

  • Gilead Sciences stock is rated a Buy
    The current Gilead Sciences [GILD] share price is $77.76. The Score for GILD is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.